ReviewBrain, behavior, & immunity - health2026
Positive affect and inflammation in women with breast cancer: A systematic review.
Review in Brain, behavior, & immunity - health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Positive affect has been implicated in psychobiological processes relevant to cancer adaptation and survivorship. However, evidence linking positive affect to objective inflammatory and immune-related biomarkers in women with breast cancer remains limited, fragmented, and methodologically heterogeneous. This systematic review was conducted to provide a focused and transparent synthesis of studies examining associations between positive affect and inflammatory or immune-related outcomes in this population. Methods: Five electronic databases were systematically searched. The review protocol was prospectively registered in PROSPERO (CRD420261304159). Studies were included if they assessed positive affect using validated measures and reported at least one objective inflammatory or immune-related biomarker in women with breast cancer. Observational studies and randomized controlled trials were eligible. Six studies met predefined PICO criteria. Results: Six studies examined associations between positive affect and inflammatory or immune-related outcomes across treatment and survivorship phases. Higher low-arousal positive affect was associated with lower C-reactive protein (CRP) in longitudinal analyses. Randomized controlled trials of Mindful Awareness Practices increased positive affect and meaning-related well-being; effects on circulating interleukin-6 (IL-6) and CRP were inconsistent, whereas transcriptional analyses indicated reduced or buffered pro-inflammatory gene expression. Increases in eudaimonic well-being were linked to reductions in conserved transcriptional response to adversity (CTRA) profiles. Affiliative positive emotions were associated with enhanced T helper type 1 (Th1)-type cytokine production. Conclusions: Current evidence suggests that positive affect may be associated with reduced inflammatory activity or more adaptive immune functioning in women with breast cancer. However, heterogeneity in affect conceptualization and biomarker assessment underscores the need for larger, methodologically harmonized longitudinal and intervention studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.